Aryl Hydrocarbon Receptor (AhR)-Mediated Signaling in iPSC-Derived Human Motor Neurons.
AhR
CYP1A1
CYP1B1
KA
L-Kyn
hiPSCs
motor neurons
stem cell model
Journal
Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453
Informations de publication
Date de publication:
04 Jul 2022
04 Jul 2022
Historique:
received:
29
05
2022
revised:
26
06
2022
accepted:
01
07
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
28
7
2022
Statut:
epublish
Résumé
Exposure to environmental pollutants and endogenous metabolites that induce aryl hydrocarbon receptor (AhR) expression has been suggested to affect cognitive development and, particularly in boys, also motor function. As current knowledge is based on epidemiological and animal studies, in vitro models are needed to better understand the effects of these compounds in the human nervous system at the molecular level. Here, we investigated expression of AhR pathway components and how they are regulated by AhR ligands in human motor neurons. Motor neurons generated from human induced pluripotent stem cells (hiPSCs) were characterized at the molecular level and by electrophysiology. mRNA levels of AhR target genes, CYP1A1 and CYP1B1 (cytochromes P450 1A1/1B1), and AhR signaling components were monitored in hiPSCs and in differentiated neurons following treatment with AhR ligands, 2,3,7,8,-tetrachlodibenzo-p-dioxin (TCDD), L-kynurenine (L-Kyn), and kynurenic acid (KA), by RT-qPCR. Changes in AhR cellular localization and CYP1A1 activity in neurons treated with AhR ligands were also assessed. The neurons we generated express motor neuron-specific markers and are functional. Transcript levels of CYP1B1, AhR nuclear translocators (ARNT1 and ARNT2) and the AhR repressor (AhRR) change with neuronal differentiation, being significantly higher in neurons than hiPSCs. In contrast, CYP1A1 and AhR transcript levels are slightly lower in neurons than in hiPSCs. The response to TCDD treatment differs in hiPSCs and neurons, with only the latter showing significant CYP1A1 up-regulation. In contrast, TCDD slightly up-regulates CYP1B1 mRNA in hiPSCs, but downregulates it in neurons. Comparison of the effects of different AhR ligands on AhR and some of its target genes in neurons shows that L-Kyn and KA, but not TCDD, regulate AhR expression and differently affect CYP1A1 and CYP1B1 expression. Finally, although TCDD does not significantly affect AhR transcript levels, it induces AhR protein translocation to the nucleus and increases CYP1A1 activity. This is in contrast to L-Kyn and KA, which either do not affect or reduce, respectively, CYP1A1 activity. Expression of components of the AhR signaling pathway are regulated with neuronal differentiation and are differently affected by TCDD, suggesting that pluripotent stem cells might be less sensitive to this toxin than neurons. Crucially, AhR signaling is affected differently by TCDD and other AhR ligands in human motor neurons, suggesting that they can provide a valuable tool for assessing the impact of environmental pollutants.
Identifiants
pubmed: 35890127
pii: ph15070828
doi: 10.3390/ph15070828
pmc: PMC9321538
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Pharmacol Ther. 2018 Apr;184:189-200
pubmed: 29024742
Mol Neurodegener. 2017 May 5;12(1):35
pubmed: 28476168
Int J Mol Sci. 2020 Dec 16;21(24):
pubmed: 33339362
Toxicol Mech Methods. 2015;25(9):689-97
pubmed: 26567990
JAMA Neurol. 2016 Jul 1;73(7):803-11
pubmed: 27159543
Neurosci Lett. 2005 Aug 12-19;384(1-2):33-7
pubmed: 15893423
Curr Genomics. 2017 Apr;18(2):106-131
pubmed: 28367072
Int J Mol Sci. 2020 Feb 04;21(3):
pubmed: 32033061
Toxicol Sci. 2010 May;115(1):89-97
pubmed: 20106948
J Genet. 2017 Mar;96(1):75-85
pubmed: 28360392
Oncol Lett. 2021 Jun;21(6):460
pubmed: 33907570
Cells. 2022 Apr 20;11(9):
pubmed: 35563695
Chem Res Toxicol. 2008 Jan;21(1):102-16
pubmed: 18076143
Environ Health Perspect. 2013 May;121(5):613-8
pubmed: 23426015
PLoS One. 2013;8(1):e53520
pubmed: 23301081
Cells. 2021 Dec 16;10(12):
pubmed: 34944067
Cell. 2006 Aug 25;126(4):663-76
pubmed: 16904174
Int J Mol Sci. 2020 Nov 28;21(23):
pubmed: 33260776
Int J Hyg Environ Health. 2019 Apr;222(3):425-433
pubmed: 30638868
Front Mol Neurosci. 2021 Dec 09;14:765712
pubmed: 34955744
Stem Cell Res Ther. 2022 Jun 3;13(1):223
pubmed: 35658933
Int J Mol Sci. 2018 Aug 24;19(9):
pubmed: 30149528
Nat Protoc. 2009;4(9):1295-304
pubmed: 19696748
Drug Metab Rev. 2021 Aug;53(3):350-374
pubmed: 34289754
Front Toxicol. 2022 Feb 03;3:787360
pubmed: 35295139
Dev Neurobiol. 2021 Jul;81(5):623-652
pubmed: 33851516
Dev Neurobiol. 2016 May;76(5):533-50
pubmed: 26243376
Int J Mol Sci. 2020 Oct 26;21(21):
pubmed: 33114713
Proc Natl Acad Sci U S A. 2012 Mar 20;109(12):4479-84
pubmed: 22392998
Biochem Biophys Res Commun. 1998 Feb 24;243(3):808-10
pubmed: 9500998
Environ Health Perspect. 2010 Nov;118(11):1571-7
pubmed: 20570779
Toxicol Sci. 2012 Aug;128(2):357-64
pubmed: 22539616
Free Radic Biol Med. 2013 May;58:52-63
pubmed: 23369756
Acta Pharm Sin B. 2021 Dec;11(12):3806-3819
pubmed: 35024308
J Immunol. 2010 Sep 15;185(6):3190-8
pubmed: 20720200
Toxicol Appl Pharmacol. 2012 Nov 15;265(1):139-45
pubmed: 22975028
Fluids Barriers CNS. 2011 Aug 25;8:23
pubmed: 21867498
Cancer Treat Rev. 2018 Feb;63:1-18
pubmed: 29197745
Front Neurosci. 2021 Feb 25;15:628983
pubmed: 33716653
Reprod Toxicol. 2020 Dec;98:174-188
pubmed: 33011216
Reprod Toxicol. 2021 Mar;100:17-34
pubmed: 33333158
Toxicol Sci. 2008 May;103(1):125-36
pubmed: 18227101
J Neurol. 2022 May;269(5):2359-2377
pubmed: 34973105
Nucleic Acids Res. 2013 Jun;41(11):5626-38
pubmed: 23599003
Trends Pharmacol Sci. 2013 Feb;34(2):136-43
pubmed: 23123095
Pharmaceutics. 2019 Dec 23;12(1):
pubmed: 31878061
Int J Mol Sci. 2022 Jan 10;23(2):
pubmed: 35054909
Environ Health Perspect. 2006 Aug;114(8):1287-92
pubmed: 16882541
Am J Pathol. 2012 Jul;181(1):211-21
pubmed: 22720799
PLoS One. 2014 Mar 24;9(3):e91946
pubmed: 24663500
J Biol Chem. 2004 Jun 4;279(23):23969-76
pubmed: 15037607
Toxicol Sci. 2005 Jul;86(1):175-84
pubmed: 15858227
J Toxicol Environ Health. 1993 Oct-Nov;40(2-3):317-35
pubmed: 7693960
Environ Health Perspect. 2021 Nov;129(11):117001
pubmed: 34747641
Chem Res Toxicol. 2020 Apr 20;33(4):860-879
pubmed: 32259433